Sjögren's syndrome epidemiology and demographics: Difference between revisions
Jump to navigation
Jump to search
Farima Kahe (talk | contribs) |
m Bot: Removing from Primary care |
||
| (14 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Sjögren's syndrome}} | {{Sjögren's syndrome}} | ||
{{CMG}} | {{CMG}} {{AE}} {{F.K}} | ||
==Overview== | ==Overview== | ||
The [[incidence]] of Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide. The [[prevalence]] of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide. The [[mortality rate]] of Sjögren's syndrome is approximately 1.38. Female are more commonly affected by Sjögren's syndrome than male. The majority of Sjögren's syndrome cases are reported in China, Japan, and California. | |||
==Epidemiology and Demographics== | ==Epidemiology and Demographics== | ||
===Incidence=== | ===Incidence=== | ||
*The incidence of Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide. | *The [[incidence]] of Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide.<ref name="pmid11393497">{{cite journal |vauthors=Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ, O'Fallon WM, Fox PC |title=Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota |journal=Mayo Clin. Proc. |volume=76 |issue=6 |pages=593–9 |date=June 2001 |pmid=11393497 |doi=10.4065/76.6.593 |url=}}</ref><ref name="pmid23983119">{{cite journal |vauthors=Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, Leroux JL, Mariette X, Mahr A |title=Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area |journal=Arthritis Care Res (Hoboken) |volume=66 |issue=3 |pages=454–63 |date=March 2014 |pmid=23983119 |doi=10.1002/acr.22115 |url=}}</ref> | ||
===Prevalence=== | ===Prevalence=== | ||
*The prevalence of | *The [[prevalence]] of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide.<ref name="pmid24938285">{{cite journal |vauthors=Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R |title=Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis |journal=Ann. Rheum. Dis. |volume=74 |issue=11 |pages=1983–9 |date=November 2015 |pmid=24938285 |doi=10.1136/annrheumdis-2014-205375 |url=}}</ref><ref name="pmid9825745">{{cite journal |vauthors=Thomas E, Hay EM, Hajeer A, Silman AJ |title=Sjögren's syndrome: a community-based study of prevalence and impact |journal=Br. J. Rheumatol. |volume=37 |issue=10 |pages=1069–76 |date=October 1998 |pmid=9825745 |doi= |url=}}</ref> | ||
===Case-fatality rate/Mortality rate=== | ===Case-fatality rate/Mortality rate=== | ||
* | *The [[mortality rate]] of Sjögren's syndrome is approximately 1.38.<ref name="pmid26412810">{{cite journal |vauthors=Singh AG, Singh S, Matteson EL |title=Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies |journal=Rheumatology (Oxford) |volume=55 |issue=3 |pages=450–60 |date=March 2016 |pmid=26412810 |pmc=5009445 |doi=10.1093/rheumatology/kev354 |url=}}</ref> | ||
===Age=== | ===Age=== | ||
* | *It can occur at any age, but the mean age is usually in the 4th to 5th decade.<ref name="pmid25114590">{{cite journal |vauthors=Patel R, Shahane A |title=The epidemiology of Sjögren's syndrome |journal=Clin Epidemiol |volume=6 |issue= |pages=247–55 |date=2014 |pmid=25114590 |pmc=4122257 |doi=10.2147/CLEP.S47399 |url=}}</ref> | ||
===Race=== | ===Race=== | ||
*There is no racial predilection to | *There is no racial predilection to Sjögren's syndrome. | ||
===Gender=== | ===Gender=== | ||
*Female are more commonly affected by Sjögren's syndrome than male. The female to male ratio is approximately 9 to 1. | *Female are more commonly affected by Sjögren's syndrome than male. The female to male ratio is approximately 9 to 1. | ||
===Region=== | ===Region=== | ||
*The majority of | *The majority of Sjögren's syndrome cases are reported in China, Japan, and California.<ref name="pmid8468491">{{cite journal |vauthors=Kang HI, Fei HM, Saito I, Sawada S, Chen SL, Yi D, Chan E, Peebles C, Bugawan TL, Erlich HA |title=Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome |journal=J. Immunol. |volume=150 |issue=8 Pt 1 |pages=3615–23 |date=April 1993 |pmid=8468491 |doi= |url=}}</ref> | ||
=== | |||
=== | |||
==References== | ==References== | ||
{{reflist|2}} | {{reflist|2}} | ||
[[Category:Medicine]] | |||
[[Category:Immunology]] | [[Category:Immunology]] | ||
[[Category:Rheumatology]] | [[Category:Rheumatology]] | ||
[[Category:Up-To-Date]] | |||
Latest revision as of 00:12, 30 July 2020
|
Sjögren's syndrome Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Sjögren's syndrome epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Sjögren's syndrome epidemiology and demographics |
|
Sjögren's syndrome epidemiology and demographics in the news |
|
Risk calculators and risk factors for Sjögren's syndrome epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Farima Kahe M.D. [2]
Overview
The incidence of Sjögren's syndrome is approximately 4 per 100,000 individuals worldwide. The prevalence of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide. The mortality rate of Sjögren's syndrome is approximately 1.38. Female are more commonly affected by Sjögren's syndrome than male. The majority of Sjögren's syndrome cases are reported in China, Japan, and California.
Epidemiology and Demographics
Incidence
Prevalence
- The prevalence of Sjögren's syndrome is approximately 43 per 100,000 individuals worldwide.[3][4]
Case-fatality rate/Mortality rate
- The mortality rate of Sjögren's syndrome is approximately 1.38.[5]
Age
- It can occur at any age, but the mean age is usually in the 4th to 5th decade.[6]
Race
- There is no racial predilection to Sjögren's syndrome.
Gender
- Female are more commonly affected by Sjögren's syndrome than male. The female to male ratio is approximately 9 to 1.
Region
- The majority of Sjögren's syndrome cases are reported in China, Japan, and California.[7]
References
- ↑ Pillemer SR, Matteson EL, Jacobsson LT, Martens PB, Melton LJ, O'Fallon WM, Fox PC (June 2001). "Incidence of physician-diagnosed primary Sjögren syndrome in residents of Olmsted County, Minnesota". Mayo Clin. Proc. 76 (6): 593–9. doi:10.4065/76.6.593. PMID 11393497.
- ↑ Maldini C, Seror R, Fain O, Dhote R, Amoura Z, De Bandt M, Delassus JL, Falgarone G, Guillevin L, Le Guern V, Lhote F, Meyer O, Ramanoelina J, Sacré K, Uzunhan Y, Leroux JL, Mariette X, Mahr A (March 2014). "Epidemiology of primary Sjögren's syndrome in a French multiracial/multiethnic area". Arthritis Care Res (Hoboken). 66 (3): 454–63. doi:10.1002/acr.22115. PMID 23983119.
- ↑ Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, Zhong R (November 2015). "Epidemiology of primary Sjögren's syndrome: a systematic review and meta-analysis". Ann. Rheum. Dis. 74 (11): 1983–9. doi:10.1136/annrheumdis-2014-205375. PMID 24938285.
- ↑ Thomas E, Hay EM, Hajeer A, Silman AJ (October 1998). "Sjögren's syndrome: a community-based study of prevalence and impact". Br. J. Rheumatol. 37 (10): 1069–76. PMID 9825745.
- ↑ Singh AG, Singh S, Matteson EL (March 2016). "Rate, risk factors and causes of mortality in patients with Sjögren's syndrome: a systematic review and meta-analysis of cohort studies". Rheumatology (Oxford). 55 (3): 450–60. doi:10.1093/rheumatology/kev354. PMC 5009445. PMID 26412810.
- ↑ Patel R, Shahane A (2014). "The epidemiology of Sjögren's syndrome". Clin Epidemiol. 6: 247–55. doi:10.2147/CLEP.S47399. PMC 4122257. PMID 25114590.
- ↑ Kang HI, Fei HM, Saito I, Sawada S, Chen SL, Yi D, Chan E, Peebles C, Bugawan TL, Erlich HA (April 1993). "Comparison of HLA class II genes in Caucasoid, Chinese, and Japanese patients with primary Sjögren's syndrome". J. Immunol. 150 (8 Pt 1): 3615–23. PMID 8468491.